{"name": "Clinical Data",
 "permalink": "clinical-data",
 "crunchbase_url": "http://www.crunchbase.com/company/clinical-data",
 "homepage_url": "http://www.clda.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@CLDA.com",
 "phone_number": "617-527-9933",
 "description": "",
 "created_at": "Fri Jan 14 03:07:07 UTC 2011",
 "updated_at": "Fri Jan 28 04:18:41 UTC 2011",
 "overview": "\u003Cp\u003EClinical Data, Inc. is focused on the development and commercialization of therapeutics, with two compounds in the areas of central nervous system and cardiovascular disorders. The Company\u00e2\u20ac\u2122s late-stage drug candidate is vilazodone, a dual-acting selective and potent serotonin reuptake inhibitor and serotonin receptor 1A (5-HT1A) partial agonist for the treatment of major depressive disorder (MDD). The Company\u00e2\u20ac\u2122s second late-stage drug candidate is apadenoson, trademarked Stedivaze, a selective adenosine receptor 2A (AR2A) agonist and coronary vasodilator in Phase III of clinical development for use in nuclear Single Photo Emission Computed Topography (SPECT) myocardial perfusion imaging. The Company also provides the FAMILION family of genetic tests for inherited cardiac syndromes, including cardiac channelopathies and cardiomyopathies. On September 30, 2009, the Company purchased all the assets of Epix Pharmaceuticals, Inc. (Epix). \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       35],
      "assets/images/resized/0011/7256/117256v1-max-150x150.png"],
     [[250,
       59],
      "assets/images/resized/0011/7256/117256v1-max-250x250.png"],
     [[382,
       91],
      "assets/images/resized/0011/7256/117256v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Andrew",
      "last_name": "J. Fromkin",
      "permalink": "andrew-j-fromkin",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "C.",
      "last_name": "Evan Ballantyne",
      "permalink": "c-evan-ballantyne",
      "image": null}},
   {"is_past": false,
    "title": "Director on the Board",
    "person":
     {"first_name": "Larry",
      "last_name": "Horner",
      "permalink": "larry-horner",
      "image": null}},
   {"is_past": false,
    "title": "scientific and management roles",
    "person":
     {"first_name": "Ben",
      "last_name": "Salisbury",
      "permalink": "ben-salisbury",
      "image":
       {"available_sizes":
         [[[140,
            140],
           "assets/images/resized/0027/5833/275833v1-max-150x150.jpg"],
          [[140,
            140],
           "assets/images/resized/0027/5833/275833v1-max-250x250.jpg"],
          [[140,
            140],
           "assets/images/resized/0027/5833/275833v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "One Gateway Center",
    "address2": "Suite 702 ",
    "zip_code": "02458 ",
    "city": "Newton",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Clinical Data completes $15.5M unit sale",
    "stoned_year": 2010,
    "stoned_month": 12,
    "stoned_day": 30,
    "source_url": "http://www.masshightech.com/stories/2010/12/27/daily42-Clinical-Data-completes-155M-unit-sale.html",
    "source_text": "",
    "source_description": "Clinical Data completes $15.5M unit sale",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Clinical Data",
      "permalink": "clinical-data"}},
   {"description": "has received U.S. Food and Drug Administration approval for its vilazodone HCl tablets to treat adults with major depressive disorder",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 24,
    "source_url": "http://www.masshightech.com/stories/2011/01/24/daily8-Clinical-Data-depression-drug-gets-FDA-approval.html",
    "source_text": null,
    "source_description": "Clinical Data depression drug gets FDA approval",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Clinical Data",
      "permalink": "clinical-data"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:CLDA"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}